Nanoly
Dr. Busha has 9 years of biotech experience including as a core member at Five Prime Therapeutics where he developed several immuno oncology protein therapeutics. He has extensive experience designing novel protein molecules, recombinant fusion proteins, and bispecific antibodies.
This person is not in any offices
Nanoly
Nanoly develops technology to eliminate refrigeration for vaccines and protein therapeutics. Nanoly has developed a polymer, NanoShield, that may be blended with any protein-based molecules to stabilize storage. Their solution is composed of non-toxic particles and is portable, convenient, and reliable.